ADMA Biologics Inc (ADMA)
6.21
+0.01
(+0.16%)
USD |
NASDAQ |
Apr 19, 15:29
ADMA Biologics Price: 6.21 for April 19, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 18, 2024 | 6.03 | 6.21 | 6.01 | 6.20 | 2.455M |
Apr 17, 2024 | 6.18 | 6.22 | 5.97 | 6.04 | 1.712M |
Apr 16, 2024 | 5.92 | 6.245 | 5.91 | 6.16 | 1.764M |
Apr 15, 2024 | 6.03 | 6.21 | 5.94 | 5.98 | 1.815M |
Apr 12, 2024 | 6.225 | 6.225 | 5.98 | 6.02 | 1.480M |
Apr 11, 2024 | 6.07 | 6.23 | 6.045 | 6.22 | 1.506M |
Apr 10, 2024 | 6.04 | 6.09 | 5.895 | 6.04 | 2.539M |
Apr 09, 2024 | 6.21 | 6.26 | 6.05 | 6.11 | 2.206M |
Apr 08, 2024 | 6.38 | 6.39 | 6.16 | 6.22 | 1.910M |
Apr 05, 2024 | 6.28 | 6.49 | 6.20 | 6.39 | 2.388M |
Apr 04, 2024 | 6.40 | 6.45 | 6.27 | 6.28 | 1.714M |
Apr 03, 2024 | 6.44 | 6.45 | 6.29 | 6.35 | 1.917M |
Apr 02, 2024 | 6.50 | 6.51 | 6.365 | 6.44 | 2.455M |
Apr 01, 2024 | 6.61 | 6.66 | 6.47 | 6.54 | 1.902M |
Mar 28, 2024 | 6.74 | 6.76 | 6.51 | 6.60 | 5.256M |
Mar 27, 2024 | 6.57 | 6.75 | 6.50 | 6.74 | 2.842M |
Mar 26, 2024 | 6.49 | 6.618 | 6.48 | 6.50 | 2.303M |
Mar 25, 2024 | 6.31 | 6.51 | 6.29 | 6.39 | 2.175M |
Mar 22, 2024 | 6.26 | 6.47 | 6.22 | 6.29 | 2.862M |
Mar 21, 2024 | 6.29 | 6.44 | 6.15 | 6.19 | 3.056M |
Mar 20, 2024 | 6.15 | 6.33 | 6.09 | 6.32 | 1.859M |
Mar 19, 2024 | 5.94 | 6.19 | 5.88 | 6.19 | 2.475M |
Mar 18, 2024 | 6.03 | 6.045 | 5.92 | 5.94 | 2.879M |
Mar 15, 2024 | 5.98 | 6.08 | 5.89 | 5.99 | 3.751M |
Mar 14, 2024 | 6.20 | 6.25 | 6.01 | 6.02 | 3.002M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.09
Minimum
Oct 11 2021
6.74
Maximum
Mar 27 2024
3.017
Average
2.94
Median
Apr 07 2020
Price Benchmarks
Vanda Pharmaceuticals Inc | 5.18 |
Puma Biotechnology Inc | 4.96 |
ANI Pharmaceuticals Inc | 65.38 |
Bristol-Myers Squibb Co | 48.95 |
Ligand Pharmaceuticals Inc | 72.10 |
Price Related Metrics
PS Ratio | 5.386 |
Price to Book Value | 10.48 |
Price to Free Cash Flow | 364.19 |
Earnings Yield | -2.09% |
Market Cap | 1.417B |
Operating PE Ratio | 64.30 |